{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:01:04Z","timestamp":1790226064621,"version":"4.1.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.semcancer.2019.05.019","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T11:21:50Z","timestamp":1559301710000},"page":"135-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"special_numbering":"C","title":["Thyroid autoimmune disorders and cancer"],"prefix":"10.1016","volume":"64","author":[{"given":"Silvia Martina","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poupak","family":"Fallahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ragusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Ruffilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Rosaria","family":"Paparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2019.05.019_bib0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000452909","article-title":"Thyroid autoimmunity and cancer","volume":"48","author":"Felicetti","year":"2017","journal-title":"Front. Horm Res."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0010","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0015","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic cells and cancer immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5603\/FHC.2014.0002","article-title":"Dendritic cells in autoimmune disorders and cancer of the thyroid","volume":"52","author":"Lewinski","year":"2014","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0025","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/1756-185X.12536","article-title":"Malignancy and autoimmunity: causally or casually related?","volume":"17","author":"Mandal","year":"2014","journal-title":"Int. J Rheum Dis."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0030","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.2741\/4705","article-title":"Thyroid cancer phenotypes in relation to inflammation and autoimmunity","volume":"23","author":"Pagano","year":"2018","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0035","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/med.21448","article-title":"Novel therapeutic clues in thyroid carcinomas: The role of targeting cancer stem cells","volume":"37","author":"Antonelli","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0040","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/ijc.27497","article-title":"Thyroid cancer in Denmark 1943-2008, before and after iodine supplementation","volume":"131","author":"Blomberg","year":"2012","journal-title":"Int. J Cancer"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12022-007-0002-z","article-title":"Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype \u2013 papillary, follicular, and anaplastic: a morphological and epidemiological study","volume":"18","author":"Albores-Saavedra","year":"2007","journal-title":"Endocr. Pathol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0050","doi-asserted-by":"crossref","first-page":"N223","DOI":"10.1177\/1010539512436874","article-title":"Increasing incidence of thyroid cancer in Shanghai, China, 1983-2007","volume":"27","author":"Wang","year":"2015","journal-title":"Asia Pac. J Public. Health"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.canrad.2011.05.002","article-title":"[Thyroid cancer following exposure to ionizing radiation]","volume":"15","author":"Schlumberger","year":"2011","journal-title":"Cancer Radiother"},{"issue":"September (7)","key":"10.1016\/j.semcancer.2019.05.019_bib0060","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s002689900132","article-title":"Epidemiologic and clinical evaluation of thyroid cancer in children from the gomel region (Belarus)","volume":"20","author":"Antonelli","year":"1996","journal-title":"World J Surg."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/1574892813666180220110729","article-title":"Lenvatinib in the therapy of aggressive thyroid cancer: State of the art and New perspectives with patents recently applied","volume":"13","author":"Ferrari","year":"2018","journal-title":"Recent. Pat. Anticancer. Drug. Discov."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/thy.1992.2.283","article-title":"Clinical picture of endemic cretinism in central apennines (montefeltro)","volume":"2","author":"Donati","year":"1992","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0075","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1210\/jc.2013-1428","article-title":"Primary thyroid lymphoma: a clinical review","volume":"98","author":"Stein","year":"2013","journal-title":"J ClinClin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/thy.2006.0194","article-title":"Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study","volume":"17","author":"Antonelli","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/thy.1995.5.25","article-title":"Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer","volume":"5","author":"Antonelli","year":"1995","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/105072503322021142","article-title":"Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer","volume":"13","author":"Antonelli","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3835(00)00697-2","article-title":"Thyroid cancer","volume":"163","author":"Gimm","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0100","series-title":"Robbins Basic Pathology","author":"Kumar","year":"2012"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0105","first-page":"2306","article-title":"Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo","volume":"39","author":"Ferrari","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0110","first-page":"2225","article-title":"Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo","volume":"39","author":"Ferrari","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0115","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1365-2265.2008.03415.x","article-title":"Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cells","volume":"70","author":"Antonelli","year":"2009","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2265.2008.03182.x","article-title":"Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests","volume":"69","author":"Antonelli","year":"2008","journal-title":"ClinClin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/EJE-08-0190","article-title":"Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration","volume":"159","author":"Antonelli","year":"2008","journal-title":"Eur J Endocrinol."},{"issue":"53","key":"10.1016\/j.semcancer.2019.05.019_bib0130","article-title":"Association between Hashimoto\u2019s thyroiditis and thyroid cancer in 64,628 patients","volume":"7","author":"Resende de Paiva","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0135","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0140","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2010.0178","volume":"20","author":"Tuttle","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mce.2009.10.003","article-title":"Thyroid cancer and inflammation","volume":"321","author":"Guarino","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0150","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0155","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0160","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/thy.2006.0306","article-title":"Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma","volume":"17","author":"Ugolini","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0165","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jamcollsurg.2006.12.037","article-title":"Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k\/Akt pathway","volume":"204","author":"Larson","year":"2007","journal-title":"J Am Coll. Surg."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0170","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/0194599812472426","article-title":"Hashimoto\u2019s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis","volume":"148","author":"Lun","year":"2013","journal-title":"Otolaryngol Head. Neck Surg."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02738789","article-title":"The relationship of lymphocytic thyroiditis to the development of thyroid carcinoma","volume":"8","author":"Okayasu","year":"1997","journal-title":"Endocr. Pathol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0180","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3727\/096504009789735431","article-title":"Clinical and biological relationship between chronic lymphocytic thyroiditis and papillary thyroid carcinoma","volume":"17","author":"Antonaci","year":"2009","journal-title":"Oncol. Res."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1398-9995.1998.tb04951.x","article-title":"The Th1\/Th2 paradigm and allergic disorders","volume":"53","author":"Romagnani","year":"1998","journal-title":"Allergy"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0195","doi-asserted-by":"crossref","first-page":"e611","DOI":"10.1016\/j.lpm.2012.10.002","article-title":"Thyroid autoimmunity","volume":"41","author":"Orgiazzi","year":"2012","journal-title":"Presse Med."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0205","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/jc.2003-032142","article-title":"Toward precise forecasting of autoimmune endocrinopathy","volume":"89","author":"Pearce","year":"2004","journal-title":"J ClinClin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0210","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","article-title":"The incidence and prevalence of thyroid autoimmunity","volume":"42","author":"McLeod","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/bmb\/ldr030","article-title":"The epidemiology of thyroid disease","volume":"99","author":"Vanderpump","year":"2011","journal-title":"Br Med. Bull"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0220","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.autrev.2016.09.009","article-title":"The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients","volume":"15","author":"Fallahi","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0225","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.autrev.2018.10.001","article-title":"The association of other autoimmune diseases in patients with graves\u2019 disease (with or without ophthalmopathy): review of the literature and report of a large series","volume":"18","author":"Ferrari","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0230","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/jc.2009-0677","article-title":"Thyroid cancer in systemic lupus erythematosus: a case-control study","volume":"95","author":"Antonelli","year":"2010","journal-title":"J Clin. Endocrinol. Metab."},{"issue":"159","key":"10.1016\/j.semcancer.2019.05.019_bib0235","article-title":"Autoimmune thyroid diseases and thyroid cancer in pemphigus: A Big data analysis","volume":"5","author":"Kridin","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0240","first-page":"480","article-title":"Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis","volume":"55","author":"Antonelli","year":"2016","journal-title":"Rheumatology (Oxf.)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0245","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/039463200902200303","article-title":"Systemic sclerosis and cancer","volume":"22","author":"Marasini","year":"2009","journal-title":"Int. J Immunopathol. Pharmacol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0250","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11912-012-0217-0","article-title":"RET TKI: potential role in thyroid cancers","volume":"14","author":"Antonelli","year":"2012","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1755-1536-4-9","article-title":"Thrombospondin 1 is a key mediator of transforming growth factor \u03b2-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)\/extracellular signal-regulated kinase (ERK)-dependent mechanism","volume":"4","author":"Chen","year":"2011","journal-title":"Fibrogenesis Tissue Repair."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0260","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1210\/er.2002-0030","article-title":"Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function","volume":"24","author":"Tomer","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0265","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2265.2011.04318.x","article-title":"Twin studies as a model for exploring the aetiology of autoimmune thyroid disease","volume":"76","author":"Brix","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0270","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1210\/jc.2011-1568","article-title":"Innate immune activation and thyroid autoimmunity","volume":"96","author":"Kawashima","year":"2011","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0275","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fendo.2017.00050","article-title":"Environmental issues in thyroid diseases","volume":"8","author":"Ferrari","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0280","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s00259-004-1519-8","article-title":"Incidence of radiation-induced graves\u2019 disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay","volume":"31","author":"Dunkelmann","year":"2004","journal-title":"Eur J Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0285","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1210\/jc.2008-0060","article-title":"Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune disease","volume":"93","author":"Agate","year":"2008","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0290","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.autrev.2016.01.001","article-title":"Smoke and autoimmunity: The fire behind the disease","volume":"15","author":"Perricone","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0295","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1530\/eje.1.02210","article-title":"The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives","volume":"155","author":"Laurberg","year":"2006","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15081735","article-title":"Nutritional and environmental factors in thyroid carcinogenesis","volume":"15","author":"Nettore","year":"2018","journal-title":"Int. J Environ. Res. Public. Health"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0305","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cen.12066","article-title":"Selenium and the thyroid gland: more good news for clinicians","volume":"78","author":"Drutel","year":"2013","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0310","first-page":"36","article-title":"Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis","volume":"21","author":"Ferrari","year":"2017","journal-title":"Eur Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0315","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.beem.2009.06.002","article-title":"Lithium and thyroid","volume":"23","author":"Lazarus","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0320","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/thy.2004.14.1047","article-title":"Stress and thyroid autoimmunity","volume":"14","author":"Mizokami","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-422X-6-5","article-title":"Viruses and thyroiditis: an update","volume":"6","author":"Desailloud","year":"2009","journal-title":"Virol J"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0330","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4254\/wjh.v7.i3.327","article-title":"Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-hodgkin\u2019s lymphoma, and cancer","volume":"7","author":"Ferri","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0335","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11154-017-9440-1","article-title":"Hepatitis C virus infection and development of type 2 diabetes mellitus: systematic review and meta-analysis of the literature","volume":"19","author":"Fabiani","year":"2018","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0340","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cyto.2006.03.012","article-title":"Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing","volume":"34","author":"Antonelli","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0345","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0350","first-page":"22","article-title":"High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthritis","volume":"27","author":"Antonelli","year":"2009","journal-title":"Clin. Exp. Rheumatol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0355","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1111\/j.1572-0241.2008.02040.x","article-title":"High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection","volume":"103","author":"Antonelli","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0360","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/EJE-06-0591","article-title":"Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis","volume":"156","author":"Antonelli","year":"2007","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0365","first-page":"1809","article-title":"Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis","volume":"35","author":"Antonelli","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0370","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1210\/jc.2008-2450","article-title":"Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in graves\u2019 disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"94","author":"Antonelli","year":"2009","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0375","doi-asserted-by":"crossref","first-page":"E413","DOI":"10.1210\/jc.2010-0923","article-title":"CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in graves\u2019 and normal thyrocytes","volume":"95","author":"Antonelli","year":"2010","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0380","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1210\/jc.2006-1571","article-title":"Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active graves\u2019 disease or toxic nodular goiter","volume":"92","author":"Antonelli","year":"2007","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0385","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0390","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.72.1.9","article-title":"Role of CXCLl1 in tumorigenesis of melanoma","volume":"72","author":"Dhawan","year":"2002","journal-title":"J Leukoc. Biol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0395","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.18632\/oncotarget.23502","article-title":"Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillarythyroid carcinoma oncogenesis?","volume":"9","author":"Urra","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0400","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/jc.2012-2555","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation?","volume":"98","author":"Rotondi","year":"2013","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0405","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semcancer.2003.10.006","article-title":"CXC chemokines in angiogenesis of cancer","volume":"14","author":"Strieter","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0410","first-page":"781","article-title":"CXCR3 in carcinoma progression","volume":"30","author":"Ma","year":"2015","journal-title":"Histol Histopathol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0415","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s12020-014-0363-2","article-title":"Is Hashimoto\u2019s thyroiditis a risk factor for medullary thyroid carcinoma? Our experience and a literature review","volume":"48","author":"Zayed","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0420","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1530\/eje.1.02020","article-title":"High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies","volume":"153","author":"Boi","year":"2005","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0425","first-page":"1910","article-title":"Is Hashimoto\u2019s thyroiditis a prognostic factor for thyroid papillary microcarcinoma?","volume":"18","author":"Bircan","year":"2014","journal-title":"Eur Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0430","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11154-018-9474-z","article-title":"The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma","volume":"19","author":"Vita","year":"2018","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0435","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/SLA.0b013e318230036d","article-title":"Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases","volume":"254","author":"Yu","year":"2011","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0440","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12032-009-9242-8","article-title":"Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer","volume":"27","author":"Lin","year":"2010","journal-title":"Med. Oncol."},{"issue":"15","key":"10.1016\/j.semcancer.2019.05.019_bib0445","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12885-015-1352-4","article-title":"Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid surgery for presumed benign thyroid disease","author":"Slijepcevic","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0450","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1245\/s10434-008-9958-2","article-title":"Incidental and nonincidental papillary thyroid microcarcinoma","volume":"15","author":"Lin","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0455","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1055\/s-0043-117892","article-title":"Hashimoto\u2019s thyroiditis is an important risk factor of papillary thyroid microcarcinoma in younger adults","volume":"49","author":"Liu","year":"2017","journal-title":"Horm Metab. Res."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0460","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/bjc.2013.597","article-title":"Cancer risk in patients with Hashimoto\u2019s thyroiditis: a nationwide cohort study","volume":"109","author":"Chen","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0465","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12022-015-9401-8","article-title":"Hashimoto\u2019s thyroiditis does not affect ultrasonographical, cytological, and histopathological features in patients with papillary thyroid carcinoma","volume":"26","author":"Baser","year":"2015","journal-title":"Endocr. Pathol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0470","first-page":"258","article-title":"[Clinicopathologic analysis of 254 cases of papillary thyroid microcarcinoma]","volume":"44","author":"Fu","year":"2015","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0475","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fendo.2017.00337","article-title":"One-third of an archivial series of papillary thyroid cancer (years 2007-2015) has coexistent chronic lymphocytic thyroiditis, which Is associated with a more favorable tumor-node-metastasis staging","volume":"8","author":"Ieni","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0480","doi-asserted-by":"crossref","first-page":"7685","DOI":"10.1007\/s13277-015-4534-4","article-title":"The impact of coexistent Hashimoto\u2019s thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma","volume":"37","author":"Qu","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0485","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/ERC-11-0028","article-title":"Hashimoto\u2019s thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine","volume":"18","author":"Fiore","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0490","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1055\/s-0043-120922","article-title":"Papillary thyroid cancer and coexisting autoimmune thyroiditis","volume":"49","author":"Veit","year":"2017","journal-title":"Horm Metab. Res."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0495","first-page":"313","article-title":"Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules","volume":"36","author":"Boi","year":"2013","journal-title":"J Endocrinol. Invest."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0500","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1210\/jc.2012-1083","article-title":"Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis","volume":"97","author":"McLeod","year":"2012","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0505","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000468928","article-title":"Thyroid autoimmunity and thyroid cancer: review focused on cytological studies","volume":"6","author":"Boi","year":"2017","journal-title":"Eur Thyroid J"},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.019_bib0510","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00405-016-4414-6","article-title":"Thyroid autoimmunity: is really associated with papillary thyroid carcinoma?","volume":"274","author":"Selek","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0515","doi-asserted-by":"crossref","first-page":"E288","DOI":"10.1210\/jc.2010-1905","article-title":"Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer","volume":"96","author":"Antonelli","year":"2011","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0520","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.biopha.2008.07.056","article-title":"Dedifferentiated thyroid cancer: a therapeutic challenge","volume":"62","author":"Antonelli","year":"2008","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0525","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12020-017-1401-7","article-title":"Thyroid autoimmune antibodies in patients with papillary thyroid carcinoma: a double-edged sword?","volume":"58","author":"Shen","year":"2017","journal-title":"Endocrine"},{"issue":"50","key":"10.1016\/j.semcancer.2019.05.019_bib0530","first-page":"922","article-title":"Thyroid autoimmunity and thyroid cancer - The pathogenic connection: A 2018 update","author":"Nagayama","year":"2018","journal-title":"Horm Metab. Res."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0535","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.tem.2014.09.001","article-title":"Hashimoto\u2019s thyroiditis and papillary thyroid cancer: are they immunologically linked?","volume":"25","author":"Ehlers","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0540","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/ERC-15-0408","article-title":"Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma","volume":"23","author":"Kim","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0545","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1530\/EJE-14-1046","article-title":"Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents","volume":"173","author":"Iliadou","year":"2015","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0550","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fendo.2017.00138","article-title":"Fallahi P. Systemic Lupus Erythematosus and Thyroid Autoimmunity","volume":"8","author":"Ferrari","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0555","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fendo.2017.00266","article-title":"Associations between systemic sclerosis and thyroid diseases","volume":"8","author":"Fallahi","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0560","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fendo.2017.00159","article-title":"Thyroid involvement in hepatitis C virus-infected patients with\/without mixed cryoglobulinemia","volume":"8","author":"Ferri","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0565","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3803\/EnM.2018.33.2.175","article-title":"Genome-Wide association studies of autoimmune thyroid diseases, thyroid function, and thyroid cancer","volume":"33","author":"Hwangbo","year":"2018","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0570","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1089\/thy.2011.0163","article-title":"The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases","volume":"22","author":"Park","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0575","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0580","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrendo.2013.56","article-title":"GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis","volume":"9","author":"Simmonds","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0585","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1086\/378588","article-title":"Common and unique susceptibility loci in graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families","volume":"73","author":"Tomer","year":"2003","journal-title":"Am J Hum. Genet"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0590","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.2337\/diabetes.53.11.3020","article-title":"Replication of an association between the lymphoid tyrosine phosphatase locus (LYP\/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus","volume":"53","author":"Smyth","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0595","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0600","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/138920207783591690","article-title":"The HLA region and autoimmune disease: associations and mechanisms of action","volume":"8","author":"Gough","year":"2007","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0605","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ng2102","article-title":"Large-scale genetic finemapping and genotype\u2013phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes","volume":"39","author":"Lowe","year":"2007","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0610","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng1540","article-title":"A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities","volume":"37","author":"Kochi","year":"2005","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0615","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/hmg\/ddp087","article-title":"Association of the thyroid stimulating hormone receptor gene (TSHR) with graves\u2019 disease","volume":"18","author":"Brand","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0620","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ng.898","article-title":"A genome-wide association study identifies two new risk loci for graves\u2019 disease","volume":"43","author":"Chu","year":"2011","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0625","series-title":"Advances in Medicine and Biology","first-page":"151","article-title":"Evaluating the role of B cells in autoimmune disease: more than just initiators of disease?","author":"Simmonds","year":"2011"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0630","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000281438","article-title":"Spectrum of human Foxe1\/TTF2 mutations","volume":"73","author":"Castanet","year":"2010","journal-title":"Horm Res. Paediatr."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0635","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng.339","article-title":"Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations","volume":"41","author":"Gudmundsson","year":"2009","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0640","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ng.1046","article-title":"Discovery of common variants associated with low TSH levels and thyroid cancer risk","volume":"44","author":"Gudmundsson","year":"2012","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0645","doi-asserted-by":"crossref","first-page":"E1674","DOI":"10.1210\/jc.2013-1941","article-title":"Genome-wide association study on differentiated thyroid cancer","volume":"98","author":"Kohler","year":"2013","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0650","doi-asserted-by":"crossref","first-page":"E2084","DOI":"10.1210\/jc.2014-1734","article-title":"Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk","volume":"99","author":"Figlioli","year":"2014","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0655","doi-asserted-by":"crossref","first-page":"8922","DOI":"10.1038\/srep08922","article-title":"Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk","volume":"5","author":"Figlioli","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0660","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/ijc.29557","article-title":"Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations","volume":"137","author":"Mancikova","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0665","doi-asserted-by":"crossref","first-page":"14517","DOI":"10.1038\/ncomms14517","article-title":"A genome-wide association study yields five novel thyroid cancer risk loci","volume":"8","author":"Gudmundsson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0670","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1093\/hmg\/ddq123","article-title":"The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl","volume":"19","author":"Takahashi","year":"2010","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0675","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000637","article-title":"The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1\/USF2 transcription factors","volume":"5","author":"Landa","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0680","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1089\/thy.2015.0665","article-title":"Papillary thyroid carcinoma: association between germline DNA variant markers and clinical parameters","volume":"26","author":"Jendrzejewski","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0685","doi-asserted-by":"crossref","first-page":"15966","DOI":"10.1038\/ncomms15966","article-title":"Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer","volume":"8","author":"Son","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0690","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1210\/jc.2017-01798","article-title":"The role of NRG1 in the predisposition to papillary thyroid carcinoma","volume":"103","author":"He","year":"2018","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0695","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1158\/1078-0432.CCR-14-0854","article-title":"Molecular pathways: targeting NRG1 fusions in lung cancer","volume":"21","author":"Fernandez-Cuesta","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0700","article-title":"Quantitative assessment of common genetic variants on FOXE1 and differentiated thyroid cancer risk","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0705","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/EP:13:1:03","article-title":"RET\/PTC rearrangement in thyroid tumors","volume":"13","author":"Nikiforov","year":"2002","journal-title":"Endocr. Pathol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0710","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00005537-199701000-00019","article-title":"Expression of the RET\/PTC fusion gene as a marker for papillary carcinoma in Hashimoto\u2019s thyroiditis","volume":"107","author":"Wirtschafter","year":"1997","journal-title":"Laryngoscope"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0715","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrc845","article-title":"Cancer after nuclear fallout: lessons from the Chernobyl accident","volume":"2","author":"Williams","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0720","first-page":"5523","article-title":"The RET\/PTC3 oncogene: metastatic solidtype papillary carcinomas in murine thyroids","volume":"58","author":"Powell","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0725","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1073\/pnas.0503039102","article-title":"Induction of a proinflammatory program in normal human thyrocytes by the RET\/PTC1 oncogene","volume":"102","author":"Borrello","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0730","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1038\/sj.onc.1206759","article-title":"Tyrosine kinase oncoprotein, RET\/PTC3, induces the secretion of myeloid growth and chemotactic factors","volume":"22","author":"Russell","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0735","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1172\/JCI200522758","article-title":"The RET\/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells","volume":"115","author":"Melillo","year":"2005","journal-title":"J Clin. Invest."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0740","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1677\/ERC-08-0337","article-title":"Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"16","author":"Antonelli","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0745","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/106689690201000104","article-title":"Prevalence of RET\/PTC rearrangements in Hashimoto\u2019s thyroiditis and papillary thyroid carcinomas","volume":"10","author":"Nikiforova","year":"2002","journal-title":"Int. J Surg. Pathol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0750","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1210\/jc.2006-0240","article-title":"RET\/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto\u2019s thyroiditis share low-level recombination events with a subset of papillary carcinoma","volume":"91","author":"Rhoden","year":"2006","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0755","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0046-8177(03)00239-9","article-title":"Expression of p63 in papillary thyroid carcinoma and in Hashimoto\u2019s thyroiditis: a pathobiologic link?","volume":"34","author":"Unger","year":"2003","journal-title":"Hum. Pathol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0760","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1073\/pnas.061032098","article-title":"p63 identifies keratinocyte stem cells","volume":"98","author":"Pellegrini","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0765","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1073\/pnas.1015557108","article-title":"Thyrotrophin receptor signaling dependence of braf-induced thyroid tumor initiation in mice","volume":"108","author":"Franco","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0770","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/modpathol.2012.152","article-title":"BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation","volume":"26","author":"Virk","year":"2013","journal-title":"Mod. Pathol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0775","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/modpathol.3800797","article-title":"Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET\/PTC rearrangements","volume":"20","author":"Sheu","year":"2007","journal-title":"Mod. Pathol"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0780","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1245\/s10434-010-1129-6","article-title":"The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma","volume":"17","author":"Lin","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0785","doi-asserted-by":"crossref","first-page":"E276","DOI":"10.1210\/jc.2013-2503","article-title":"The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations","volume":"99","author":"Jung","year":"2014","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0790","first-page":"361","article-title":"[Clinical pathological characteristics of resectable papillary thyroid microcarcinoma]","volume":"39","author":"Shi","year":"2017","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0795","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1089\/thy.2013.0036","article-title":"Clinicopathologic implications of the BRAF(V600E) mutation in papillary thyroid cancer: a subgroup analysis of 3130 cases in a single center","volume":"23","author":"Lim","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0800","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/cen.12194","article-title":"BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto\u2019s thyroiditis lymphocytic infiltration is present","volume":"79","author":"Marotta","year":"2013","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0805","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11596-015-1476-4","article-title":"BRAF(v(6)(0)(0)E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis","volume":"35","author":"Ma","year":"2015","journal-title":"J Huazhong Univ. Sci. Technolog Med. Sci."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0810","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fendo.2018.00471","article-title":"The role of the transcription factor nuclear factor-kappa B in thyroid autoimmunity and cancer","volume":"9","author":"Giuliani","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0815","doi-asserted-by":"crossref","first-page":"12826","DOI":"10.1016\/S0021-9258(18)42350-2","article-title":"Tumor necrosis factor-a activates nuclear factor kB and induces manganous superoxide dismutase and phosphodiesterase mRNA in human papillary thyroid carcinoma cells","volume":"267","author":"Pang","year":"1992","journal-title":"J Biol Chem."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0820","doi-asserted-by":"crossref","first-page":"11453","DOI":"10.1074\/jbc.270.19.11453","article-title":"Hormonal modulation of major histocompatibility complex class I gene expression involves an enhancer A-binding complex consisting of fra-2 and the p50 subunit of NF-kB","volume":"270","author":"Giuliani","year":"1995","journal-title":"J Biol Chem."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0825","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mce.2009.10.010","article-title":"Role of NF-kB in thyroid cancer","volume":"321","author":"Pacifico","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0830","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1158\/1078-0432.CCR-15-1374","article-title":"Molecular pathways: the balance between cancer and the immune system challenges the therapeutic specificity of targeting nuclear factor-kB signaling for cancer treatment","volume":"22","author":"Zeligs","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0835","doi-asserted-by":"crossref","first-page":"629","DOI":"10.18388\/abp.2008_3023","article-title":"The role of nuclear factor-kB in the development of autoimmune diseases: a link between genes and environment","volume":"55","author":"Kurylowicz","year":"2008","journal-title":"Acta Biochim Pol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0840","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/thy.2011.0480","article-title":"Demonstration of innate immune responses in the thyroid gland: potential to sense danger and a possible trigger for autoimmune reactions","volume":"23","author":"Kawashima","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0845","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fendo.2016.00144","article-title":"Excessive cytosolic DNA fragments as a potential trigger of graves\u2019 disease: an encrypted message sent by animal models","volume":"7","author":"Luo","year":"2016","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0850","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-065X.2012.01105.x","article-title":"Pathogenetic importance and therapeutic implications of NF-kB in lymphoid malignancies","volume":"246","author":"Lim","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0855","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.3390\/genes9010024","article-title":"NF-kB: two sides of the same coin","volume":"9","author":"Pires","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0860","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1038\/sj.onc.1207029","article-title":"TGF-b-induced apoptosis in human thyrocytes is mediated by p27kip1 reduction and is overridden in neoplastic thyrocytes by NF-kB activation","volume":"22","author":"Bravo","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0865","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.beem.2017.04.013","article-title":"The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer","volume":"31","author":"De Falco","year":"2017","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0870","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrendo.2010.46","article-title":"Immunity, thyroid function and pregnancy: molecular mechanisms","volume":"6","author":"Weetman","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0875","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1530\/eje.1.02080","article-title":"Fetal microchimerism in Hashimoto\u2019s thyroiditis: a quantitative approach","volume":"154","author":"Klintschar","year":"2006","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0880","first-page":"3315","article-title":"Intrathyroidal fetal microchimerism in graves\u2019 disease","volume":"87","author":"Ando","year":"2002","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0885","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1089\/thy.2009.0424","article-title":"Parity is not related to autoimmune thyroid disease in a population-based study of Japanese-brazilians","volume":"20","author":"Sgarbi","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0890","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1158\/0008-5472.CAN-08-0672","article-title":"Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair","volume":"68","author":"Cirello","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0895","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/105072501300176417","article-title":"Environmental iodine intake affects the type of nonmalignant thyroid disease","volume":"11","author":"Laurberg","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0900","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2265.2011.04008.x","article-title":"A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population","volume":"75","author":"Pedersen","year":"2011","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0905","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2013-2912","article-title":"Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin","volume":"98","author":"Latrofa","year":"2013","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0910","series-title":"Global Iodine Nutrition Scorecard","year":"2014"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0915","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1210\/jcem-9-10-1007","article-title":"Incidence of carcinoma of the thyroid in nodular goiter","volume":"9","author":"Cole","year":"1949","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0920","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/1097-0142(196608)19:8<1063::AID-CNCR2820190804>3.0.CO;2-A","article-title":"Development of carcinoma of the thyroid in iodine-deficient mice","volume":"19","author":"Schaller","year":"1966","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0925","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1210\/endo.143.7.8914","article-title":"Radiation-induced thyroid carcinogenesis as a function of time and dietary iodine supply: an in vivo model of tumorigenesis in the rat","volume":"143","author":"Boltze","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0930","first-page":"71","article-title":"Influence of iodine deficiency and iodine prophylaxis on thyroid cancer histotypes and incidence in endemic goiter area","volume":"26","author":"Huszno","year":"2003","journal-title":"J Endocrinol. Invest."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0935","doi-asserted-by":"crossref","first-page":"49","DOI":"10.12659\/MSM.883736","article-title":"The changing incidence of thyroid carcinoma in Shenyang, China before and after universal salt iodization","volume":"19","author":"Dong","year":"2013","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0940","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1168556","article-title":"The immune network in thyroid cancer","volume":"5","author":"Galdiero","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0945","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/14737140.2018.1417845","article-title":"Current and future immunotherapies for thyroid cancer","volume":"18","author":"Antonelli","year":"2018","journal-title":"Expert Rev. Anticancer. Ther."},{"key":"10.1016\/j.semcancer.2019.05.019_bib0950","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/ERC-12-0313","article-title":"Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation","volume":"20","author":"Cunha","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.019_bib0955","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41416-018-0296-2","article-title":"Combinations of BRAF inhibitor and anti-PD-1\/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer","volume":"119","author":"Gunda","year":"2018","journal-title":"Br J Cancer"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X18301597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X18301597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:40:18Z","timestamp":1760917218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X18301597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":191,"alternative-id":["S1044579X18301597"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.05.019","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid autoimmune disorders and cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}